捷迈邦美(ZBH)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 ZBH 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement Q1 2026
Item	Category	Value	YoY
Net sales	revenue	2.09B	9.30%
Segment profit	profit	373.20M	27.68%
Operating expenses	cost	1.71B	5.98%
Income (loss) from continuing operations before income taxes, noncontrolling interest	profit	301.30M	31.57%
Interest expense, net	revenue	68.80M	3.93%
Other (expense) income, net	revenue	3.00M	3.45%
Net earnings	profit	238.30M	30.50%
Provision for income taxes	cost	63.00M	35.48%
Net earnings of zimmer biomet holdings, inc.	profit	238.10M	30.82%
Less: net earnings attributable to noncontrolling interest	cost	200000	-66.67%

Products Breakdown
Segment	Value	YoY
Knees	828.60M	4.50%
S E T	562.20M	19.49%
Hips	524.10M	5.71%
Technology And Data, Bone Cement and Surgical	171.80M	14.61%

Balance Sheet Q1 2026
Item	Category	Value
Inventories	assets	2.25B
Accounts receivable, less allowance for credit losses	assets	1.73B
Prepaid expenses and other current assets	assets	562.90M
Cash and cash equivalents	assets	424.20M
Total current assets	assets	4.96B
Goodwill	assets	9.93B
Intangible assets, net	assets	4.55B
Property, plant and equipment, net	assets	2.21B
Other assets	assets	1.07B
Total assets	assets	22.72B
Total stockholders' equity	liabilities	12.68B
Total liabilities	liabilities	10.04B
Noncontrolling interest	liabilities	8.20M
Treasury stock, 106.9 million shares (104.8 million shares in 2022)	assets	9.14B
Accumulated other comprehensive loss	liabilities	190.40M
Total zimmer biomet holdings, inc. stockholders' equity	equity	12.67B
Long-term debt	liabilities	6.30B
Liabilities, current	liabilities	2.86B
Other long-term liabilities	liabilities	630.70M
Deferred income taxes, net	liabilities	249.90M
Aggregate	equity	22.00B
Current portion of long-term debt	liabilities	1.18B
Other current liabilities	liabilities	1.03B
Accounts payable	liabilities	361.20M
Salaries, wages and benefits	liabilities	293.90M
Retained earnings	liabilities	11.80B
Paid-in capital	liabilities	10.20B
Common stock, $0.01 par value, one billion shares authorized, 319.3 million shares as of march 31, 2026 (318.7 million as of december 31, 2025) issued	liabilities	3.20M

Operating Activities – 3M 2026
Item	Value
Depreciation and amortization	270.00M
Net earnings	238.30M
Share-based compensation	24.20M
Increase (decrease) in other operating assets and liabilities, net, total	23.50M
Increase (decrease) in receivables, total	14.50M
Income taxes	-7.40M
Increase (decrease) in inventories, total	-20.90M
Accounts payable and accrued liabilities	-183.00M

Investing Activities – 3M 2026
Item	Value
Payments for (proceeds from) hedge, investing activities, total	-300000
Payment for (proceeds from) other investing activity	-6.20M
Payments to acquire property, plant, and equipment, total	-36.30M
Payments related to contractual obligations	-39.00M
Additions to instruments	-77.20M

Financing Activities – 3M 2026
Item	Value
Proceeds from employee stock compensation plans	12.30M
Other financing activities	-15.60M
Payments of ordinary dividends, common stock	-46.90M
Business combination contingent consideration payments	-69.00M
Payments for repurchase of common stock	-250.10M

Cash Balance – 3M 2026
Item	Value
Cash and cash equivalents, beginning of period	591.90M
Cash and cash equivalents, end of period	424.20M